The vendor landscape in the global biological seed treatment market is increasingly dynamic, finds Transparency Market Research (TMR). This is on account of copious investments by several agrochemical companies on new biological seed treatments. A number of players in various developed regions of the global biological seed treatment market are engaged in bagging regulatory approvals for their biological products. Numerous agricultural technology companies are also working relentlessly on educating the end users of the benefits of advanced seed treatments, which helps them get strongholds in the global biological seed treatment market.
Growing number of players, notably Monsanto Company and Bayer CropScience, are offering seed companies biological seed treatments to help them customize agronomic solutions in order to bolster agricultural productivity. Other well-entrenched players in the global biological seed treatment market are Valent Biosciences Corporation, BASF SE, Italpollina SpA, and Syngenta AG.
The opportunities in the global biological seed treatment market is expected to rise at robust CAGR of 10.2% during 2017 - 2026. By the end of this period, the global biological seed treatment market will reach worth of US$715 mn.
Among the various biological seed treatment types, those used for bacterial resistance will fetch major share of revenues over the assessment timeline. US$ 00 million worth of biological seed treatment solutions are expected to be used in bacterial intervention in plants’ growth by 2026 end.
Regionally, North America holds sway in the global biological seed treatment market. In the years ahead, the region is expected to rise at the most attractive growth rate and attain US$ 306 Mn by 2026 end. The growth is increasingly propelled by rapid growth in agricultural technologies in the region and growing acceptance of biological seed treatments among agronomists.